Product Name | NS-304 (Selexipag; ACT-293987) |
---|---|
CAS | 475086-01-2 |
Formula | C26H32N4O4S |
MW | 496.62 |
Appearance | White to yellow powder |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | ¥300.00 | Visible after login | |
5 mg | 3-5days | ¥500.00 | Visible after login | |
10 mg | 3-5days | ¥800.00 | Visible after login |
Product Name | NS-304 (Selexipag; ACT-293987) |
---|---|
CAS | 475086-01-2 |
Formula | C26H32N4O4S |
MW | 496.62 |
Appearance | White to yellow powder |
Selexipag, also known as ACT-293987 and NS-304, is a a first-in-class orally available selective non-prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT-333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.